{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-027377","form_type":"8-K","ticker":"INNV","cik":"0001834376","company_name":"InnovAge Holding Corp.","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.944555+00:00","generated_at":"2026-06-18T18:47:26.153034+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InnovAge appoints Christine Bent as COO effective March 20, 2023; Maria Lozzano transitions to Senior Advisor","bullets":["Christine Bent appointed COO effective March 20, 2023; replaces Maria Lozzano who becomes Senior Advisor to CEO and COO through August 4, 2023.","Bent's employment agreement includes $455,000 base salary, 50% target bonus, $400,000 annual RSU grant, and initial $575,000 RSU grant vesting over 3 years.","Lozzano will receive base salary continuation for 12 months post-separation, pro-rata bonus, and healthcare coverage under transition agreement.","Bent previously SVP and COO at Prime Therapeutics; also held leadership roles at Allina Health and Atrius Health."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-027377","json":"https://secwatch.observer/filing/0001104659-23-027377.json","markdown":"https://secwatch.observer/filing/0001104659-23-027377.md","text":"https://secwatch.observer/filing/0001104659-23-027377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/0001104659-23-027377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/tm238090d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T18:47:26.153034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f68b1bb3a","claim":"Christine Bent was appointed as Chief Operations Officer at InnovAge Holding Corp..","evidence_excerpt":"On March 1, 2023, InnovAge Holding Corp. (the “Company”) announced that its Board of Directors (the “Board”) has appointed Christine Bent as Chief Operations Officer of the Company effective March 20, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/0001104659-23-027377-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operations Officer"}],"fact_type":"executive_change"},{"claim_id":"ecca9c3c10","claim":"Maria Lozzano changed role as Chief Operating Officer at InnovAge Holding Corp..","evidence_excerpt":"Ms. Bent will replace Maria Lozzano, who will step down from her role as Chief Operating Officer, effective as of the Transition Date, and will remain employed by the Company as a Senior Advisor to Ms. Bent and the Company’s Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/0001104659-23-027377-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}